Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses

Antiviral Research

Volumn 124, Issue , 2015, Pages 1-10

  Kang, Hyunju ^a,e   Kim, Chonsaeng ^c   Kim, Dong Eun ^a,e   Song, Jae Hyoung ^d   Choi, Miri ^a,e   Choi, Kwangman ^a,f   Kang, Mingu ^a   Lee, Kyungjin ^c   Kim, Hae Soo ^c   Shin, Jin Soo ^c   Kim, Janghwan ^a   Han, Sang Bae ^e   Lee, Mi Young ^f   Lee, Su Ui ^a   Lee, Chong Kyo ^c   Kim, Meehyein ^c   Ko, Hyun Jeong ^d   Van Kuppeveld, Frank J M ^g   Cho, Sungchan ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c Korea Research Institute of Chemical Technology   (South Korea)

^d Kangwon National University   (South Korea)

^e Chungbuk National University   (South Korea)

^f Soonchunhyang University   (South Korea)

^g UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antiviral inhibitor; Enteroviruses; Gemcitabine; Ribavirin

Indexed keywords

GEMCITABINE; POLYPROTEIN; RIBAVIRIN; VIRUS PROTEIN; ANTIVIRUS AGENT; DEOXYCYTIDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; COXSACKIEVIRUS B3; DRUG POTENTIATION; ENTEROVIRUS; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; IC50; INTERNAL RIBOSOME ENTRY SITE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REPLICON; RHINOVIRUS INFECTION; RNA SYNTHESIS; VERO CELL LINE; VIRUS INHIBITION; VIRUS REPLICATION; ANALOGS AND DERIVATIVES; ANIMAL; CELL PROLIFERATION; DRUG EFFECTS; ENTEROVIRUS A; ENTEROVIRUS INFECTIONS; HEK293 CELL LINE; PHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CELL PROLIFERATION; DEOXYCYTIDINE; DRUG SYNERGISM; ENTEROVIRUS; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HEK293 CELLS; HELA CELLS; HUMANS; REPLICON; RIBAVIRIN; VERO CELLS; VIRUS REPLICATION;

EID: 84946198346     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.10.011     Document Type: Article

References (50)

1. M. Arita, T. Wakita, and H. Shimizu Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime J. Gen. Virol. 90 2009 1869 1879
2. M. Baba, R. Pauwels, J. Balzarini, P. Herdewijn, E. De Clercq, and J. Desmyter Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro Antimicrob. Agents Chemother. 31 1987 1613 1617
3. J. Balzarini, D.A. Cooney, M. Dalal, G.J. Kang, J.E. Cupp, E. DeClercq, S. Broder, and D.G. Johns 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis Mol. Pharmacol. 32 1987 798 806
4. T.C. Chen, H.Y. Chang, P.F. Lin, J.H. Chern, J.T. Hsu, C.Y. Chang, and S.R. Shih Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71 Antimicrob. Agents Chemother. 53 2009 2740 2747
5. H.J. Choi, C.H. Lim, J.H. Song, S.H. Baek, and D.H. Kwon Antiviral activity of raoulic acid from raoulia australis against picornaviruses. phytomedicine Int. J. Phytotherapy Phytopharm. 16 2009 35 39
6. T.C. Chou Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Pharmacol. Rev. 58 2006 621 681
7. M. Chumakov, M. Voroshilova, L. Shindarov, I. Lavrova, L. Gracheva, G. Koroleva, S. Vasilenko, I. Brodvarova, M. Nikolova, S. Gyurova, M. Gacheva, G. Mitov, N. Ninov, E. Tsylka, I. Robinson, M. Frolova, V. Bashkirtsev, L. Martiyanova, and V. Rodin Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria Arch. Virol. 60 1979 329 340
8. A. Claude, B.P. Zhao, C.E. Kuziemsky, S. Dahan, S.J. Berger, J.P. Yan, A.D. Armold, E.M. Sullivan, and P. Melancon GBF1: a novel golgi-associated BFA-resistant guanine nucleotide exchange factor that displays specificity for ADP-ribosylation factor 5 J. Cell Biol. 146 1999 71 84
9. C.L. Clouser, J. Chauhan, M.A. Bess, J.L. van Oploo, D. Zhou, S. Dimick-Gray, L.M. Mansky, and S.E. Patterson Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine Bioorg. Med. Chem. Lett. 22 2012 6642 6646
10. C.L. Clouser, S.E. Patterson, and L.M. Mansky Exploiting drug repositioning for discovery of a novel HIV combination therapy J. Virol. 84 2010 9301 9309
11. L. De Colibus, X. Wang, J.A. Spyrou, J. Kelly, J. Ren, J. Grimes, G. Puerstinger, N. Stonehouse, T.S. Walter, Z. Hu, J. Wang, X. Li, W. Peng, D.J. Rowlands, E.E. Fry, Z. Rao, and D.I. Stuart More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules Nat. Struct. Mol. Biol. 21 2014 282 288
12. O.V. Denisova, L. Kakkola, L. Feng, J. Stenman, A. Nagaraj, J. Lampe, B. Yadav, T. Aittokallio, P. Kaukinen, T. Ahola, S. Kuivanen, O. Vapalahti, A. Kantele, J. Tynell, I. Julkunen, H. Kallio-Kokko, H. Paavilainen, V. Hukkanen, R.M. Elliott, J.K. De Brabander, X. Saelens, and D.E. Kainov Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection J. Biol. Chem. 287 2012 35324 35332
13. P.S. Dragovich, T.J. Prins, R. Zhou, S.E. Webber, J.T. Marakovits, S.A. Fuhrman, A.K. Patick, D.A. Matthews, C.A. Lee, C.E. Ford, B.J. Burke, P.A. Rejto, T.F. Hendrickson, T. Tuntland, E.L. Brown, J.W. Meador 3rd, R.A. Ferre, J.E. Harr, M.B. Kosa, and S.T. Worland Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements J. Med. Chem. 42 1999 1213 1224
14. N. Falah, R. Montserret, V. Lelogeais, I. Schuffenecker, B. Lina, J.C. Cortay, and S. Violot Blocking human enterovirus 71 replication by targeting viral 2A protease J. Antimicrob. Chemother. 67 2012 2865 2869
15. N. Fuzzati Analysis methods of ginsenosides. Journal of chromatography. B Anal. Technol. Biomed. Life Sci. 812 2004 119 133
16. W.Y. Gao, D.G. Johns, M. Tanaka, and H. Mitsuya Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine Mol. Pharmacol. 55 1999 535 540
17. J.D. Graci, and C.E. Cameron Mechanisms of action of ribavirin against distinct viruses Rev. Med. Virol. 16 2006 37 48
18. B.A. Heinz, and L.M. Vance The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus J. Virol. 69 1995 4189 4197
19. P. Hernandez, P. Olivera, A. Duenas-Gonzalez, M.A. Perez-Pastenes, A. Zarate, V. Maldonado, and J. Melendez-Zajgla Gemcitabine activity in cervical cancer cell lines Cancer Chemother. Pharmacol. 48 2001 488 492
20. H. Kang, J. Song, K. Choi, H. Kim, M. Choi, S.Y. Lee, C. Kim, S.J. Lee, M.J. Song, H. Kang, S.H. Back, S.B. Han, and S. Cho Efficient lytic induction of Kaposi's sarcoma-associated herpesvirus (KSHV) by the anthracyclines Oncotarget 5 2014 8515 8527
21. H. Kim, K. Choi, H. Kang, S.Y. Lee, S.W. Chi, M.S. Lee, J. Song, D. Im, Y. Choi, and S. Cho Identification of a novel function of CX-4945 as a splicing regulator PloS One 9 2014 e94978
22. J.H. Kim, J.B. Park, P.K. Bae, H.S. Kim, D.W. Kim, J.K. Ahn, and C.K. Lee Establishment and use of a cell line expressing HSV-1 thymidine kinase to characterize viral thymidine kinase-dependent drug-resistance Antivir. Res. 54 2002 163 174
23. J. Liu, Y. Yang, Y. Xu, C. Ma, C. Qin, and L. Zhang Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication Virol. J. 8 2011 483
24. P.C. McMinn An overview of the evolution of enterovirus 71 and its clinical and public health significance FEMS Microbiol. Rev. 26 2002 91 107
25. A. Meyerhans, J.P. Vartanian, C. Hultgren, U. Plikat, A. Karlsson, L. Wang, S. Eriksson, and S. Wain-Hobson Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools J. Virol. 68 1994 535 540
26. G. Palacios, and M.S. Oberste Enteroviruses as agents of emerging infectious diseases J. Neurovirol. 11 2005 424 433
27. N. Pariente, A. Airaksinen, and E. Domingo Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus J. Virol. 77 2003 7131 7138
28. N. Pariente, S. Sierra, P.R. Lowenstein, and E. Domingo Efficient virus extinction by combinations of a mutagen and antiviral inhibitors J. Virol. 75 2001 9723 9730
29. D.C. Pevear, M.J. Fancher, P.J. Felock, M.G. Rossmann, M.S. Miller, G. Diana, A.M. Treasurywala, M.A. McKinlay, and F.J. Dutko Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors J. Virol. 63 1989 2002 2007
30. J. Qing, Y. Wang, Y. Sun, J. Huang, W. Yan, J. Wang, D. Su, C. Ni, J. Li, Z. Rao, L. Liu, and Z. Lou Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator PLoS Pathog. 10 2014 e1004422
31. J.M. Rawson, R.H. Heineman, L.B. Beach, J.L. Martin, E.K. Schnettler, M.J. Dapp, S.E. Patterson, and L.M. Mansky 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors Bioorg. Med. Chem. 21 2013 7222 7228
32. C.M. Ruiz-Jarabo, C. Ly, E. Domingo, and J.C. de la Torre Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) Virology 308 2003 37 47
33. M.H. Sawyer Enterovirus infections: diagnosis and treatment Semin. Pediatr. Infect. Dis. 13 2002 40 47
34. L. Shang, M. Xu, and Z. Yin Antiviral drug discovery for the treatment of enterovirus 71 infections Antivir. Res. 97 2013 183 194
35. S.R. Shih, M.C. Tsai, S.N. Tseng, K.F. Won, K.S. Shia, W.T. Li, J.H. Chern, G.W. Chen, C.C. Lee, Y.C. Lee, K.C. Peng, and Y.S. Chao Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone Antimicrob. Agents Chemother. 48 2004 3523 3529
36. J. Song, S.G. Yeo, E.H. Hong, B.R. Lee, J.W. Kim, J. Kim, H. Jeong, Y. Kwon, H. Kim, S. Lee, J.H. Park, and H.J. Ko Antiviral activity of Hederasaponin B from Hedera helix against enterovirus 71 Subgenotypes C3 and C4a Biomol. Ther. 22 2014 41 46
37. J.H. Song, H.J. Choi, H.H. Song, E.H. Hong, B.R. Lee, S.R. Oh, K. Choi, S.G. Yeo, Y.P. Lee, S. Cho, and H.J. Ko Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3 J. Ginseng Res. 38 2014 173 179
38. R. Ulferts, L. van der Linden, H.J. Thibaut, K.H. Lanke, P. Leyssen, B. Coutard, A.M. De Palma, B. Canard, J. Neyts, and F.J. van Kuppeveld Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C Antimicrob. Agents Chemother. 57 2013 1952 1956
39. C. Urbinati, P. Chiodelli, and M. Rusnati Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis Molecules 13 2008 2758 2785
40. H.M. van der Schaar, P. Leyssen, H.J. Thibaut, A. de Palma, L. van der Linden, K.H. Lanke, C. Lacroix, E. Verbeken, K. Conrath, A.M. Macleod, D.R. Mitchell, N.J. Palmer, H. van de Poel, M. Andrews, J. Neyts, and F.J. van Kuppeveld A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIbeta Antimicrob. Agents Chemother. 57 2013 4971 4981
41. F.J. van Kuppeveld, J.M. Galama, J. Zoll, and W.J. Melchers Genetic analysis of a hydrophobic domain of coxsackie B3 virus protein 2B: a moderate degree of hydrophobicity is required for a cis-acting function in viral RNA synthesis J. Virol. 69 1995 7782 7790
42. M.J. van Ooij, D.A. Vogt, A. Paul, C. Castro, J. Kuijpers, F.J. van Kuppeveld, C.E. Cameron, E. Wimmer, R. Andino, and W.J. Melchers Structural and functional characterization of the coxsackievirus B3 CRE(2C): role of CRE(2C) in negative- and positive-strand RNA synthesis J. General Virol. 87 2006 103 113
43. S.M. Wang, H.Y. Lei, K.J. Huang, J.M. Wu, J.R. Wang, C.K. Yu, I.J. Su, and C.C. Liu Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema J. Infect. Dis. 188 2003 564 570
44. E. Wessels, R.A. Notebaart, D. Duijsings, K. Lanke, B. Vergeer, W.J. Melchers, and F.J. van Kuppeveld Structure-function analysis of the coxsackievirus protein 3A: identification of residues important for dimerization, viral rna replication, and transport inhibition J. Biol. Chem. 281 2006 28232 28243
45. J.L. Whitton, C.T. Cornell, and R. Feuer Host and virus determinants of picornavirus pathogenesis and tropism. Nature reviews Microbiology 3 2005 765 776
46. K.X. Wu, M.M. Ng, and J.J. Chu Developments towards antiviral therapies against enterovirus 71 Drug Discov. Today 15 2010 1041 1051
47. Y. Wu, Z. Lou, Y. Miao, Y. Yu, H. Dong, W. Peng, M. Bartlam, X. Li, and Z. Rao Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China Protein. Cell 1 2010 491 500
48. Z. Yin, Y.L. Chen, W. Schul, Q.Y. Wang, F. Gu, J. Duraiswamy, R.R. Kondreddi, P. Niyomrattanakit, S.B. Lakshminarayana, A. Goh, H.Y. Xu, W. Liu, B. Liu, J.Y. Lim, C.Y. Ng, M. Qing, C.C. Lim, A. Yip, G. Wang, W.L. Chan, H.P. Tan, K. Lin, B. Zhang, G. Zou, K.A. Bernard, C. Garrett, K. Beltz, M. Dong, M. Weaver, H. He, A. Pichota, V. Dartois, T.H. Keller, and P.Y. Shi An adenosine nucleoside inhibitor of dengue virus Proc. Natl. Acad. Sci. U. S. A. 106 2009 20435 20439
49. H. Zeichhardt, M.J. Otto, M.A. McKinlay, P. Willingmann, and K.O. Habermehl Inhibition of poliovirus uncoating by disoxaril (WIN 51711) Virology 160 1987 281 285
50. G. Zhang, F. Zhou, B. Gu, C. Ding, D. Feng, F. Xie, J. Wang, C. Zhang, Q. Cao, Y. Deng, W. Hu, and K. Yao In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection Arch. Virol. 157 2012 669 679